semaglutide approved for obesity European Commission Approves 7.2 mg Once-Weekly Wegovy Dose Adults With Semaglutide vs Tirzepatide for Weight

These effects may reflect a reduced compensatory response in appetite stimulation and energy conservation that typically follows rapid weight loss or abrupt cessation of therapy [17,2022]

Cytokine (2020) 131:155117

Epub 2015 May 7

The team also pointed out the likelihood of abuse among patients with diagnosed eating disorders and children and adolescents involved in competitive sports like wrestling, martial arts, gymnastics, and ballet

However, Saxenda (liraglutide) and Wegovy (semaglutide) are approved as weight loss medications for certain children aged 12 years and older with obesity

They are used as an adjunct within supervised medical weight-loss programmes, not as a standalone treatment